Oscar Health (NYSE:OSCR) Shares Down 4.2%

Oscar Health, Inc. (NYSE:OSCRGet Free Report) was down 4.2% on Monday . The company traded as low as $16.02 and last traded at $16.08. Approximately 899,065 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 3,359,885 shares. The stock had previously closed at $16.78.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on OSCR shares. Robert W. Baird started coverage on shares of Oscar Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price objective for the company. Raymond James began coverage on Oscar Health in a report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target on the stock. Wells Fargo & Company increased their price target on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, June 12th. Piper Sandler reissued an “overweight” rating and set a $25.00 price target on shares of Oscar Health in a report on Wednesday. Finally, Baird R W raised Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Three equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $19.75.

View Our Latest Stock Report on Oscar Health

Oscar Health Price Performance

The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The firm has a market cap of $3.89 billion, a PE ratio of -41.00 and a beta of 1.61. The stock has a 50 day simple moving average of $19.35 and a 200-day simple moving average of $15.83.

Oscar Health (NYSE:OSCRGet Free Report) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.34. The firm had revenue of $2.14 billion during the quarter, compared to analyst estimates of $1.99 billion. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The business’s quarterly revenue was up 45.8% compared to the same quarter last year. During the same quarter last year, the business posted ($0.18) earnings per share. Equities analysts anticipate that Oscar Health, Inc. will post -0.05 earnings per share for the current fiscal year.

Insider Activity

In related news, CAO Victoria Baltrus sold 7,674 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $149,336.04. Following the completion of the transaction, the chief accounting officer now owns 127,754 shares of the company’s stock, valued at approximately $2,486,092.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Alessandrea C. Quane sold 25,550 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $497,203.00. Following the completion of the transaction, the executive vice president now owns 237,347 shares of the company’s stock, valued at approximately $4,618,772.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Victoria Baltrus sold 7,674 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $149,336.04. Following the completion of the transaction, the chief accounting officer now directly owns 127,754 shares of the company’s stock, valued at approximately $2,486,092.84. The disclosure for this sale can be found here. Insiders sold a total of 81,655 shares of company stock worth $1,589,006 over the last 90 days. Corporate insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

Institutional investors have recently added to or reduced their stakes in the company. Avalon Trust Co bought a new stake in Oscar Health in the first quarter worth about $69,000. Prevail Innovative Wealth Advisors LLC bought a new stake in Oscar Health in the fourth quarter worth about $92,000. Farallon Capital Management LLC bought a new stake in Oscar Health in the first quarter worth about $164,000. Simplicity Wealth LLC bought a new stake in Oscar Health in the second quarter worth about $179,000. Finally, Cornerstone Investment Partners LLC bought a new stake in Oscar Health in the first quarter worth about $178,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.